A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
| Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
| PERTPCR | B.pertussis DNA (PCR) | - | MATERIAL: Abstrich; METHODE: PCR | |||
| B2GPG | B2-Glykoprotein IgG | U/ml | 0.000 | - | 8.000 | MATERIAL: Serum, METHODE: ELISA |
| B2GPM | B2-Glykoprotein IgM | U/ml | 0.000 | - | 8.000 | MATERIAL: Serum, METHODE: ELISA |
| BTRANS | B2-Transferrin (Nasensekret) | ng/ml | 0.00 | - | 5.00 | MATERIAL: Abstrich |
| BABDIVG | Babesia divergens IgG-AK | 0.0 | - | 16.0 | MATERIAL: Serum; Methode: IFT | |
| BABMICG | Babesia microti IgG-AK | 0.0 | - | 16.0 | MATERIAL: Serum; Methode: IFT | |
| BACLOFEN | Baclofen | ug/l | 80.0 | - | 400.0 | MATERIAL: Serum, METHODE: LC-MS |
| BARS | Barbiturate (S) | ug/l | 0.0 | - | 500.0 | MATERIAL: Serum, METHODE: FPIA |
| BARH | Barbiturate i.H. | ng/ml | 0.0 | - | 200.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| BAU | Barium i.H. | ug/l | 0.00 | - | 10.00 | MATERIAL: Spontanharn, METHODE: AAS |
| BA | Barium im Serum | ug/l | 0.00 | - | 2.80 | MATERIAL: Serum, METHODE: AAS |
| BARTHENSG | Bartonella henselae IgG Ak | - | MATERIAL: Serum, METHODE: IFT | |||
| BARTHENSM | Bartonella henselae IgM Ak | - | MATERIAL: Serum, METHODE: IFT | |||
| BMAEPID | Basalmembran-AK (epidermal) | Titer | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT |
| BMAGLOM_V | Basalmembran-AK (glomerulär) | U/ml | 0.0 | - | 6.9 | MATERIAL: Serum/Vollblut, METHODE: IFT |
| BMAGLOM | Basalmembran-AK (glomerulär) | 0.00 | - | 19.00 | MATERIAL: Serum, METHODE: ELISA | |
| BASOP | Basophile | % | - | MATERIAL: Punktat, | ||
| BASO | Basophile | % | 0.00 | - | 2.00 | MATERIAL: EDTA, |
| BASOA | Basophile (abs.) | /µl | 0.0 | - | 200.0 | |
| BCR_ABL1 | BCR-ABL1 Translokationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
| BEHENSRE | Behensäure C22:0 | umol/l | 26.50 | - | 110.00 | MATERIAL: Serum Methode: GC-MS |
| BJS | Bence Jones Protein | - | MATERIAL: Serum, METHODE: Immunfixation | |||
| BJH | Bence Jones Protein i.H. | - | MATERIAL: Spontanharn, METHODE: Immunfixation | |||
| BENZS | Benzodiazepine (S) | - | MATERIAL: Serum, METHODE: FPIA | |||
| BENZH | Benzodiazepine i.H. | ng/ml | 0.0 | - | 200.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| BENZECGOS | Benzoylecgonin (S) | ug/l | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: FPIA |
| BETA | Beta | % | 7.90 | - | 13.70 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
| BETAA | Beta | g/dl | 0.570 | - | 0.990 | |
| B1ADREZAK | Beta 1 adrenerge Rezeptor AK | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, Methode: ELISA |
| B2ADREZAK | Beta 2 adrenerge Rezeptor AK | U/ml | 0.00 | - | 8.00 | MATERIAL: Serum, Methode: ELISA |
| B2MG | Beta-2-Mikroglobulin | mg/l | 0.970 | - | 2.640 | MATERIAL: Serum, METHODE: MEIA |
| B2MGU | Beta-2-Mikroglobulin i.H. | mg/l | 0.0000 | - | 0.3000 | MATERIAL: Spontanharn, METHODE: MEIA |
| BCAROT | Beta-Carotin | ug/l | 40.00 | - | 322.00 | MATERIAL: Serum, METHODE: HPLC |
| BDEFENST | Beta-Defensin i.St. | ng/ml | 15.0 | - | 60.0 | MATERIAL: Stuhl, METHODE: ELISA |
| BHCG | Beta-HCG | mIE/ml | 0.00 | - | 5.00 | MATERIAL: Serum, METHODE: MEIA |
| BHCGF | Beta-HCG frei | IU/l | - | MATERIAL: Serum, METHODE: TRACE | ||
| BILID | Bilirubin direkt | mg/dl | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: photometrisch |
| BILIG | Bilirubin gesamt | mg/dl | 0.000 | - | 1.200 | MATERIAL: Serum, METHODE: photometrisch |
| BIOTESTOS | Bioverfügbares Testosteron | - | Material: Serum/ Vollblut | |||
| TESTOSBV% | Bioverfügbares Testosteron [%] | % | - | MATERIAL: Serum/Vollblut, METHODE: Calc. | ||
| BIPERIDEN | Biperiden | ug/l | 1.00 | - | 6.50 | MATERIAL: Serum, METHODE: LC-MS |
| BISPHENOLA | Bisphenol A | ug/l | < | 2.00 | MATERIAL: Serum Methode: GC-MS | |
| BKVPCR | BK-Polyomavirus DNA (PCR) | - | MATERIAL: EDTA-Blut; METHODE: PCR | |||
| BLEIH | Blei i.H. | ug/dl | 0.000 | - | 15.000 | MATERIAL: Spontanharn, METHODE: AAS |
| BLEIV | Blei im Vollblut (EDTA) | ug/dl | 0.000 | - | 9.000 | MATERIAL: EDTA, METHODE: AAS |
| ARTHRITIS | BLOCK ARTHRITIS | - | ||||
| EXANTHEM | BLOCK EXANTHEM | - | ||||
| GASTROENT | BLOCK GASTROENTERITIS | - | ||||
| LYMPHADVIR | BLOCK LYMPHADENITIS | - | ||||
| MYALGIE | BLOCK MYALGIE | - | ||||
| MYOCARD | BLOCK MYOCARDITIS | - | ||||
| PAROTITIS | BLOCK PAROTITIS | - | ||||
| PNEUMONIE | BLOCK PNEUMONIE | - | ||||
| STD | BLOCK SEX.TRANSM.DISEASES | - | ||||
| STATFEB | BLOCK ST.FEBRILIS | - | ||||
| TINNITUS | BLOCK TINNITUS | - | ||||
| ZECKENBISS | BLOCK ZECKENBISS | - | ||||
| BBA | Blutbild (abs.) | - | MATERIAL: EDTA | |||
| BB | Blutbild mit Diff | - | MATERIAL: EDTA | |||
| BG | Blutgruppe | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
| BGRH | Blutgruppe/Rhesus | - | MATERIAL: EDTA, METHODE: Gelzentrifug. | |||
| STBLUT | Blut i.St. | - | MATERIAL: Stuhl | |||
| BSR1 | Blutsenkung nach 1h | mm | 0.0 | - | 10.0 | MATERIAL: EDTA, METHODE: Westergreen |
| BZBEL | Blutzuckerbelastung (OGTT) | - | MATERIAL: Fluorid-Blut | |||
| BZ | Blutzucker nüchtern | mg/dl | 60.0 | - | 100.0 | MATERIAL: Fluorid, METHODE: photometrisch |
| BZPPR | Blutzucker postprandial | mg/dl | 60.0 | - | 180.0 | MATERIAL: Fluorid, METHODE: photometrisch |
| BZT | Blutzucker Tagesprofil | - | MATERIAL: Fluorid-Blut, METHODE: photometrisch | |||
| BORV | Bor im Vollblut (EDTA) | ug/l | 14.0 | - | 85.0 | MATERIAL: EDTA, METHODE: |
| BDVAK | Borna-Disease-Virus Ak IgG | - | MATERIAL: Serum, | |||
| BDVAG | Borna-Virus RNA | - | MATERIAL: Liquor | |||
| BORPCR | Borrelia burgd. DNA (PCR) | - | MATERIAL: Liquor/Punktat, METHODE: PCR | |||
| BORBLOTG | Borrelien Blot IgG | - | MATERIAL: Serum, METHODE: Immunoblot | |||
| BORBLOTM | Borrelien Blot IgM | - | MATERIAL: Serum, METHODE: Immunoblot | |||
| BORELISPOT | Borrelien - EliSpot | - | MATERIAL: CPDA, METHODE: ELISpot Assay | |||
| BORG | Borrelien IgG | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: ELISA |
| BORG_L | Borrelien IgG i.L. | - | MATERIAL: Liquor, METHODE: ELFA | |||
| BORM | Borrelien IgM | - | MATERIAL: Serum, METHODE: ELISA | |||
| BORM_L | Borrelien IgM i.L. | - | MATERIAL: Liquor, METHODE: ELFA | |||
| BORLTT | Borrelien LTT | - | MATERIAL: spez.Abnahme CPDA Heparin, METHODE: | |||
| BP180GAK | BP180 (NC16A-4x) IgG AK | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
| BP230GAK | BP230 IgG AK | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
| BDNF | Brain-derived neurot. Factor | ng/ml | 18.30 | - | 31.40 | MATERIAL: Serum, |
| BRIVARAC | Brivaracetam | mg/l | 0.500 | - | 0.900 | MATERIAL: Serum, METHODE: LC-MS |
| BROMAZEPAM | Bromazepam | ug/l | 50.00 | - | 200.00 | MATERIAL: Serum, METHODE: LC-MS/MS |
| BROMU | Brom i.H. | ug/ml | - | MATERIAL: Spontanharn, | ||
| BROMIDS | Bromid im Serum | mg/dl | - | MATERIAL: Serum, Methode: | ||
| BROMH | Brom im 24h H. | mg/24h | 0.00 | - | 5.00 | MATERIAL: 24h-Sammelharn, METHODE: ICP-MS |
| BRUCG | Brucella IgG-EIA | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum, METHODE: EIA |
| BRUCM | Brucella IgM-EIA | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: EIA |
| BRUCKBR | Brucella KBR | Titer | 0.0 | - | 20.0 | MATERIAL: Serum, Methode: KBR |
| BUPRH | Buprenorphin i.H. | 0.0 | - | 5.0 | MATERIAL: Spontanharn, METHODE: CEDIA | |
| BUPRO | Bupropion | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
| BUPRO_GES | Bupropion+Hydroxybupropion | ug/l | 850.00 | - | 1500.00 | |
| BABS | B-Zellen absolut | /mm3 | 90.0 | - | 660.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
| BREL | B-Zellen relativ | % | 7.0 | - | 23.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |